We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac Mapping Tools

By HospiMedica staff writers
Posted on 13 Oct 2005
A new segmentation tool for use during electrophysiologic (EP) procedures and a computer-based system to facilitate procedures to treat irregular heartbeats have been developed to enhance speed and flexibility of visualization and navigation during EP procedures.

"The introduction of EnSite system version 5.1 is a significant advance in 3D [three-dimensional] navigation and visualization technology,” said Jane J. More...
Song, president of the St. Jude Medical atrial fibrillation division (St. Paul, MN, USA). "Combined with the EnSite Verismo segmentation tool, this upgrade will provide greater clinical value for physicians through increased speed, flexibility, and control during procedures. These capabilities are a crucial part of effective EP procedures.”

The EnSite 5.1 software features MultiPoint technology, which is designed to increase the speed and efficiency of cardiac mapping procedures. The EnSite Verismo segmentation tool uses computed tomography (CT) and magnetic resonance imaging (MRI) scans to construct 3D cardiac models that assist in procedure planning, geometry creation, and validation of therapy delivery. The EnSite system was included in St. Jude Medical's acquisition of Endocardial Solutions, Inc. (ESI; St. Paul, MN, USA) in January 2005.

Using the EnSite system, electrophysiology clinicians can create 3D models of their patients' cardiac anatomy during EP procedures and navigate the catheters used in those procedures. The system then collects and organizes activation and voltage data from the inner surface of the heart, allowing physicians to visualize arrhythmias on the 3D model and determine a treatment strategy.





Related Links:
St. Jude Medical
Endocardial Solutions

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.